COVID-19 监测与非裔美国人药物使用障碍：对数据和政策的考察。
COVID-19 surveillance and Black American substance use disorder: An examination of data and policy.
机构信息
University of California San Francisco, United States of America; Nursing Pathways at City College of San Francisco, Mail Stop C340, 50 Frida Kahlo Way, San Francisco, CA 94112, United States of America.
出版信息
J Subst Abuse Treat. 2021 Apr;123:108243. doi: 10.1016/j.jsat.2020.108243. Epub 2020 Dec 11.
Research has cited structural racism as a determinate of black Americans' susceptibility to COVID-19. Using the flu surveillance system as a template, the U.S. has collected surveillance data on COVID-19. The U.S. also has rich databases on drug use and treatment. The U.S. should use data, combined with epidemiologic modeling that includes accurate proxies for structural racism, to direct policy, treatment, and COVID-19 vaccine distribution priorities. This paper provides a baseline of where we are and suggestions to consider to achieve health parity in populations of color.
研究指出，结构性种族主义是导致美国黑人易感染 COVID-19 的一个决定因素。美国以流感监测系统为模板，收集了 COVID-19 的监测数据。美国还有关于药物使用和治疗的丰富数据库。美国应该利用数据，结合包括准确的结构性种族主义替代指标在内的流行病学模型，来指导政策、治疗和 COVID-19 疫苗的分配重点。本文提供了一个基准，说明了我们所处的位置，并提出了一些建议，以实现有色人种群体的健康平等。
Zotero 插件